TickerFacts.

Roivant Sciences Ltd. (ROIV): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.42B
As of 2026-03-31
$1.25B
As of 2026-06-30
-5.4%
3-year compound annual growth
-7.1%
5-year compound annual growth
$6.49B2021-03-31: $2.06B2022-03-31: $2.06B2023-03-31: $1.68B2024-03-31: $6.49B2025-03-31: $2.72B2026-03-31: $1.42B$1.42B
2021-03-31 Cash & Equivalents (USD) 2026-03-31
Period endedCash & EquivalentsChange YoYSource filing
2026-03-31$1.42B-47.7%2026-05-20, Balance as of period end
2025-03-31$2.72B-58.2%2026-05-20, Balance as of period end
2024-03-31$6.49B+287.3%2025-05-29, Balance as of period end
2023-03-31$1.68B-18.6%2024-05-30, Balance as of period end
2022-03-31$2.06B+0.3%2023-06-28, Balance as of period end
2021-03-31$2.06Bn/a2022-06-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Roivant Sciences Ltd. (ROIV)2026-03-31$1.42B-47.7%
Coya Therapeutics, Inc. (COYA)2025-12-31$46.82M+22.1%
Aclaris Therapeutics, Inc. (ACRS)2025-12-31$19.96M-18.8%
Bolt Biotherapeutics, Inc. (BOLT)2025-12-31$11.70M+62.4%
Adagene Inc. (ADAG)2025-12-31$74.52M-12.5%
BioAge Labs, Inc. (BIOA)2025-12-31$188.89M-46.7%
Xenon Pharmaceuticals Inc. (XENE)2025-12-31$199.16M+39.6%
Ovid Therapeutics Inc. (OVID)2025-12-31$13.15M-50.0%
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31$37.57M+31.0%

Compare ROIV, COYA, ACRS, BOLT side by side · Screen every company in Pharmaceutical Preparations ↗